NEW YORK (GenomeWeb News) – Abbott Laboratories said yesterday that it has received the CE Mark for a PCR-based test that can detect a new variant strain of Chlamydia trachomatis that has been found in one in five chlamydia cases in Sweden.
 
The assay, which may now be sold for clinical diagnostic use throughout the European Union, is run on Abbott’s automated m2000 real-time PCR system. Abbott said that the assay would be offered in Europe as part of its alliance with Celera.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.